how do glp 1 agonists work for diabetes Targeting GLP-1, GIP & GCG in Obesity and Type 2 Research GLP-1 Receptor Agonists as Treatments

If the gastrointestinal side effects are tolerable, Mounjaro may prove to be the most effective medication available for people living with type 2 diabetes

This is because in 1983 the hamster glucagon precursor was cloned by Graeme Bell and colleagues using a degenerate oligonucleotide predicted by the glucagon sequence (6)

Cardiovascular outcome studies Although multiple clinical trials evaluating cardiovascular events associated with GLP-1 RA use as the primary outcome are currently ongoing (Table 1), abundant non-primary outcome data are available from many clinical trials on the efficacy of GLP-1 RAs marketed earlier, such as exenatide (DURATION studies) and liraglutide (LEAD studies)

Therefore, current treatment guidelines recommend maintenance of an optimal weight and stringent management of lipid levels in addition to glycemic control [3]

The US study analysed 606,434 US veterans with type 2 diabetes, who were monitored for up to three years

GLP-1 agonists excel at weight reduction and cardiovascular protection, while SGLT2 inhibitors lead in renal preservation and heart failure management